Family history, genetic testing, and clinical risk prediction: pooled analysis of CHEK2 1100delC in 1,828 bilateral breast cancers and 7,030 controls - Fletcher, O; Johnson, N; Dos Santos Silva, I (Cancer Epidemiol Biomarkers Prev, 2009)
et al.